Vanguard Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Sell |
9,380,547
-2,278,394
| -20% | -$5.49M | ﹤0.01% | 2502 |
|
|
2025
Q1 | $25.8M | Sell |
11,658,941
-162,483
| -1% | -$359K | ﹤0.01% | 2399 |
|
|
2024
Q4 | $64.4M | Sell |
11,821,424
-60,316
| -0.5% | -$329K | ﹤0.01% | 2058 |
|
|
2024
Q3 | $98.7M | Buy |
11,881,740
+1,133,130
| +11% | +$9.42M | ﹤0.01% | 1876 |
|
|
2024
Q2 | $77M | Buy |
10,748,610
+710,484
| +7% | +$5.09M | ﹤0.01% | 1959 |
|
|
2024
Q1 | $87M | Buy |
10,038,126
+34,232
| +0.3% | +$297K | ﹤0.01% | 1934 |
|
|
2023
Q4 | $65.5M | Sell |
10,003,894
-213,388
| -2% | -$1.4M | ﹤0.01% | 2075 |
|
|
2023
Q3 | $102M | Sell |
10,217,282
-341,685
| -3% | -$3.42M | ﹤0.01% | 1801 |
|
|
2023
Q2 | $131M | Sell |
10,558,967
-230
| -0% | -$2.86K | ﹤0.01% | 1704 |
|
|
2023
Q1 | $148M | Buy |
10,559,197
+169,218
| +2% | +$2.37M | ﹤0.01% | 1618 |
|
|
2022
Q4 | $149M | Buy |
10,389,979
+177,381
| +2% | +$2.54M | ﹤0.01% | 1596 |
|
|
2022
Q3 | $261M | Sell |
10,212,598
-220,435
| -2% | -$5.63M | 0.01% | 1224 |
|
|
2022
Q2 | $296M | Sell |
10,433,033
-79,184
| -0.8% | -$2.25M | 0.01% | 1181 |
|
|
2022
Q1 | $371M | Sell |
10,512,217
-21,392
| -0.2% | -$754K | 0.01% | 1165 |
|
|
2021
Q4 | $441M | Buy |
10,533,609
+426,670
| +4% | +$17.9M | 0.01% | 1081 |
|
|
2021
Q3 | $496M | Buy |
10,106,939
+1,758,189
| +21% | +$86.3M | 0.01% | 976 |
|
|
2021
Q2 | $348M | Buy |
8,348,750
+2,992,196
| +56% | +$125M | 0.01% | 1245 |
|
|
2021
Q1 | $191M | Buy |
5,356,554
+643,102
| +14% | +$22.9M | 0.01% | 1602 |
|
|
2020
Q4 | $132M | Buy |
+4,713,452
| New | +$132M | ﹤0.01% | 1695 |
|